Effect of Brefeldin A on transcytotic vesicular pathway and bile secretion: a study on the isolated perfused rat liver and isolated rat hepatocyte couplets. 1995

D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
II Department of Gastroenterology, University of Rome La Sapienza, Italy.

This study investigated the effect of Brefeldin A (BFA) on the transcytotic vesicular pathway labeled with horseradish peroxidase (HRP) in both isolated rat hepatocyte couplets (IRHC) and the isolated perfused rat liver (IPRL). To evaluate the role of the transcytotic vesicular pathway on bile secretion, the effect of BFA on bile secretion in the IPRL was then investigated. In the basolateral area of IRHC, BFA showed no effect on the density and percentage of area of HRP-labeled vesicles. However, HRP-labeled vesicles tended to accumulate in the juxtanuclear area of BFA-treated hepatocytes (P < .001 vs. controls). In the pericanalicular area, on the other hand, HRP-labeled vesicles were depleted compared with controls (P < .001). In keeping with these findings, although the early peak remained unchanged, BFA inhibited as much as 50% of the late peak of HRP excretion in bile, after a pulse load of HRP in the IPRL. Bile flow and the biliary secretion of bile salts (BS) and phospholipids were not modified by BFA in isolated livers perfused without BS in the perfusate or with 1 mumol/min taurocholate (TCA). In BFA-treated livers, peak bile flow and BS output decreased by 20% (P < .05 vs. controls) only when a 5 mumol TCA bolus was administered. In conclusion, this study demonstrates that BFA inhibits the transcytotic vesicular pathway in the liver. However, BFA has no significant effect on bile secretion either in basal conditions or during perfusion with physiological amounts of BS. BFA slightly decreases bile flow and BS output only after an overload of BS, providing evidence against the physiological relevance of the transcytotic vesicular pathway in the process of bile formation.

UI MeSH Term Description Entries
D007365 Intercellular Junctions Direct contact of a cell with a neighboring cell. Most such junctions are too small to be resolved by light microscopy, but they can be visualized by conventional or freeze-fracture electron microscopy, both of which show that the interacting CELL MEMBRANE and often the underlying CYTOPLASM and the intervening EXTRACELLULAR SPACE are highly specialized in these regions. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p792) Cell Junctions,Cell Junction,Intercellular Junction,Junction, Cell,Junction, Intercellular,Junctions, Cell,Junctions, Intercellular
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D011500 Protein Synthesis Inhibitors Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. Protein Synthesis Antagonist,Protein Synthesis Antagonists,Protein Synthesis Inhibitor,Antagonist, Protein Synthesis,Antagonists, Protein Synthesis,Inhibitor, Protein Synthesis,Inhibitors, Protein Synthesis,Synthesis Antagonist, Protein,Synthesis Inhibitor, Protein
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003517 Cyclopentanes A group of alicyclic hydrocarbons with the general formula R-C5H9. Cyclopentadiene,Cyclopentadienes,Cyclopentene,Cyclopentenes,Cyclopentane
D006735 Horseradish Peroxidase An enzyme isolated from horseradish which is able to act as an antigen. It is frequently used as a histochemical tracer for light and electron microscopy. Its antigenicity has permitted its use as a combined antigen and marker in experimental immunology. Alpha-Peroxidase,Ferrihorseradish Peroxidase,Horseradish Peroxidase II,Horseradish Peroxidase III,Alpha Peroxidase,II, Horseradish Peroxidase,III, Horseradish Peroxidase,Peroxidase II, Horseradish,Peroxidase III, Horseradish,Peroxidase, Ferrihorseradish,Peroxidase, Horseradish
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary

Related Publications

D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
September 1988, Gastroenterology,
D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
July 1995, Hepatology (Baltimore, Md.),
D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
August 1993, Hepatology (Baltimore, Md.),
D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
September 2006, World journal of gastroenterology,
D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
January 1993, Biochemical pharmacology,
D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
February 1994, The American journal of physiology,
D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
July 1990, Gastroenterology,
D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
January 1991, The American journal of physiology,
D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
October 1992, Hepatology (Baltimore, Md.),
D Alvaro, and A Benedetti, and A Gigliozzi, and A Bini, and S Furfaro, and C Bassotti, and T La Rosa, and A M Jezequel, and L Capocaccia
October 2006, European journal of pharmacology,
Copied contents to your clipboard!